Helse Sør-Øst RHF announces a call for applications with total funding of approx. 135 million NOKs for health research in the region. The call has both a thematic open structure, available to all research areas in the specialist healthcare services, and a targeted part where funding is decided after strategic assessment of applications within prioritised thematic areas. In addition, applications submitted from non-university hospitals will be considered for strategically earmarked research awards.
Application categories
For 2026, research funding is available within the following application categories:
See the guidelines and an overview of mandatory attachments for applications in all categories.
Selection of thematic group for distribution of the application to the relevant review panel
The application must be submitted electronically via the online platform eSøknad. The application form includes a list used to allocate the application to one of the following groups:
The members of the review panels are carefully selected to reflect the thematic profile within each group and the subject areas included within these groups. A correct classification of the application is therefore central in the application process and instrumental for the distribution of applications to the members in each panel.
Please note that subgroups have been added to the subject groups for clinical somatic research and biomedical research with a translational perspective. The subgroups may be merged if the number of applications in one group is particularly low.
Please note: The PI is personally responsible for classifying the application in the correct group. The administration in Helse Sør-Øst RHF cannot re-classifiy the application after the application deadline. .
Please see an overview of the composition of each subject group.
Prioritised research areas
The board of Helse Sør-Øst RHF has decided to earmark up to 10 million NOKs of the call to research projects within the following three areas:
Please refer to our website for a description of the prioritised thematic areas.
The Principal Investigator (PI) must:
Hold a PhD,
Be employed at a recognized institution in the region at ≥20% throughout the project,
Have their main employment within Helse Sør‑Øst RHF, with only one application per PI allowed
Funding is capped at NOK 4.5 million per PI annually, including active and new grants .
Available schemes:
PhD fellowships,
Postdoctoral grants,
Open project support (multi-year research),
Plus international mobility stipends
Applications must use the correct electronic form (PhD/Postdoc/Project) and classifications cannot be changed later .
Applicants must select one of five discipline-based panels:
Mental health/addiction, public health, clinical somatic, biomedical/translational, health informatics .
Correct classification ensures evaluation by the right experts; errors aren’t rectified post-deadline .
The Board reserves up to NOK 10 million for strategic themes:
Quality improvement & patient safety,
Decentralized services & seamless care pathways,
Digitalization .
Applications matching these topics may have increased visibility.
Proposals are assessed on:
Scientific rigor,
Methodological quality,
Clear benefit to patient care or healthcare processes .
At least two independent reviewers—primarily national/international experts with >90% international representation—evaluate submissions .
Around 30–40% of applications are triaged before committee discussion.
Remaining proposals (~60%) go to full panel review, with disagreements triggering group debate—helping borderline applications.
All proposals must describe user participation (e.g., patient involvement), or justify its absence
Applications must meet all requirements—attachments, format, page limits, and budget guidelines—to avoid outright rejection .
Awardees report progress via eRapport, publicly shared and used in regional annual reporting.
Administrative fairness is monitored by internal and external oversight mechanisms .
Success Predictor | Recommendation |
---|---|
PI and employment eligibility | Ensure PI meets all criteria and applies once |
Budget awareness | Check current commitments vs NOK 4.5 M cap |
Grant type selection | Choose correct application form |
Panel selection | Classify your discipline accurately |
Strategic alignment | Frame project within regional priority themes |
Scientific & clinical quality | Showcase rigorous methods and health relevance |
User involvement | Include co-design with patients or justify omission |
Proposal compliance | Meet format, attachment, and budget requirements |
Reporting readiness | Prepare for eRapport compliance and transparency |
🧭 Pro Tips for Applicants
Clarify PI’s capacity and avoid oversubscription—ensure eligibility and singular submission.
Frame within priority areas to boost strategic relevance.
Choose your panel wisely—ensure relevance to reviewer expertise.
Describe user involvement clearly—e.g., advisory groups, patient co-authorship.
Plan for transparent reporting—structure data collection for eRapport.
Anticipate triage criteria—address scientific robustness and health utility up front.
The Principal Investigator (PI) should register as the applicant. The PI must have a PhD and be employed in at least 20% position at the applicant institution from the application deadline and throughout the project period. In addition, the PI's main position must be in the Helse Sør-Øst health region. Please refer to the requirements for the PI and a list of approved applicant institutions.
Please note: A PI may only submit one application through their applicant institution in this call for proposals.
Helse Sør-Øst RHF has set an upper annual limit for the amount awarded per PI. This limit is NOK 4.5 million for 2026 and includes both ongoing and new research projects, independent of the application category.
Eligible Countries:
Sponsor Institute/Organizations: Helse Sør-Øst RHF
Sponsor Type: Corporate/Non-Profit
Address: Postboks 404 2303 Hamar
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 04, 2025
$297,039
Affiliation: Helse Sør-Øst RHF
Address: Postboks 404 2303 Hamar
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.